Antioxidant and bioenergetic coupling between neurons and astrocytes. (Q37993651)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22417747%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

Antioxidant and bioenergetic coupling between neurons and astrocytes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22417747%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22417747%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Juan Bolanos

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22417747%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Seila Fernandez-Fernandez

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22417747%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

language of work or name

English

0 references

publication date

1 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22417747%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22417747%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

443

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22417747%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22417747%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

3-11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22417747%20AND%20SRC:MED&resulttype=core&format=json

Should the word 'dementia' be forgotten?

25 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Mitochondria and reactive oxygen and nitrogen species in neurological disorders and stroke: Therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

How mitochondria produce reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Oxidative stress and neurodegeneration: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Nitric oxide synthases in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Synthesis of nitric oxide in CNS glial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Roles of nitric oxide in brain hypoxia-ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Role of endothelium-derived nitric oxide in the regulation of blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Bright and dark sides of nitric oxide in ischemic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Glial and neuronal control of brain blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Nitrosylation and nitration of mitochondrial complex I in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Provoking neuroprotection by peroxynitrite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Extracellular superoxide dismutase, nitric oxide, and central nervous system O2 toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Inflammatory neurodegeneration and mechanisms of microglial killing of neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Nitric Oxide Potently and Reversibly Deenergizes Mitochondria at Low Oxygen Tension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

A transient inhibition of mitochondrial ATP synthesis by nitric oxide synthase activation triggered apoptosis in primary cortical neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Nitric oxide, cell bioenergetics and neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Glycolysis: a bioenergetic or a survival pathway?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Metabolism and functions of glutathione in brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

The glutathione system of peroxide detoxification is less efficient in neurons than in astroglial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Impairment of brain mitochondrial function by reactive nitrogen species: the role of glutathione in dictating susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

A comparison of thiol peroxidase mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Emerging roles of thioredoxin cycle enzymes in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Peroxide detoxification by brain cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Alterations in glutathione S-transferase pi expression following exposure to MPP+ -induced oxidative stress in the blood of Parkinson's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Biochemical, physiological and medical aspects of ubiquinone function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Animal and human studies with the mitochondria-targeted antioxidant MitoQ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Levodopa activates apoptosis signaling kinase 1 (ASK1) and promotes apoptosis in a neuronal model: implications for the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Levodopa deactivates enzymes that regulate thiol-disulfide homeostasis and promotes neuronal cell death: implications for therapy of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

A disruption in iron-sulfur center biogenesis via inhibition of mitochondrial dithiol glutaredoxin 2 may contribute to mitochondrial and cellular iron dysregulation in mammalian glutathione-depleted dopaminergic cells: implications for Parkinson's d

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Tripartite synapses: astrocytes process and control synaptic information

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Astrocytes are endogenous regulators of basal transmission at central synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

21 January 2018

Sweet sixteen for ANLS.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Activity-dependent regulation of energy metabolism by astrocytes: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Astrocyte glycogen and brain energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Astrocyte glycogen sustains neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316,819 ([R-R*,S*]-5-chloro-N-[2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmethyl)propyl]-1H-indole-2-carboxamide).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Astrocytes: biology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Molecular dissection of reactive astrogliosis and glial scar formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Nrf2:INrf2 (Keap1) signaling in oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Nrf2 signaling in coordinated activation of antioxidant gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Nuclear factor erythroid 2-related factor 2 facilitates neuronal glutathione synthesis by upregulating neuronal excitatory amino acid transporter 3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Regulation of Neuronal Oxidative and Nitrosative Stress by Endogenous Protective Pathways and Disease Processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

In vivo modulation of the Parkinsonian phenotype by Nrf2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Induction of the protective antioxidant response element pathway by 6-hydroxydopamine in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Nrf2-mediated protection against 6-hydroxydopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic [correction of electrophillic] phase II inducers

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Controlled enzymatic production of astrocytic hydrogen peroxide protects neurons from oxidative stress via an Nrf2-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Mild oxidative stress activates Nrf2 in astrocytes, which contributes to neuroprotective ischemic preconditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Activation of the antioxidant response element in primary cortical neuronal cultures derived from transgenic reporter mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Regional vulnerability to endogenous and exogenous oxidative stress in organotypic hippocampal culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Selective susceptibility of different populations of sympathetic neurons to diabetic neuropathy in vivo is reflected by increased vulnerability to oxidative stress in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Oct1 loss of function induces a coordinate metabolic shift that opposes tumorigenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Selective vulnerability of the hippocampus in brain ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Mouse hippocampal organotypic tissue cultures exposed to in vitro "ischemia" show selective and delayed CA1 damage that is aggravated by glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Transcriptional paradigms in mammalian mitochondrial biogenesis and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

PGC-1alpha, a new therapeutic target in Huntington's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Neurobiology and treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Knockdown of glutamate-cysteine ligase by small hairpin RNA reveals that both catalytic and modulatory subunits are essential for the survival of primary neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Glutathione release from cultured brain cells: multidrug resistance protein 1 mediates the release of GSH from rat astroglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Inducible alterations of glutathione levels in adult dopaminergic midbrain neurons result in nigrostriatal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Glutathione depletion and overproduction both initiate degeneration of nigral dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Peroxynitrite protects neurons against nitric oxide-mediated apoptosis. A key role for glucose-6-phosphate dehydrogenase activity in neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

The cytosolic redox state of astrocytes: Maintenance, regulation and functional implications for metabolite trafficking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Poly(ADP-ribose) polymerase-1 protects neurons against apoptosis induced by oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Regulation of the pentose phosphate cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Bioenergetic dysfunction in Huntington's disease human cybrids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2-kinase pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Failure to maintain glycolysis in anoxic nerve terminals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Bioenergetic analysis of isolated cerebrocortical nerve terminals on a microgram scale: spare respiratory capacity and stochastic mitochondrial failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Role of retinal glial cells in neurotransmitter uptake and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Simultaneous single neuron recording of O2 consumption, [Ca2+]i and mitochondrial membrane potential in glutamate toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Glutamate mediates acute glucose transport inhibition in hippocampal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Cdh1/Hct1-APC is essential for the survival of postmitotic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Evidence supporting the existence of an activity-dependent astrocyte-neuron lactate shuttle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Lactate: the ultimate cerebral oxidative energy substrate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Astrocyte-neuron lactate transport is required for long-term memory formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Neuron-glia metabolic coupling and plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Energy metabolism in astrocytes: high rate of oxidative metabolism and spatiotemporal dependence on glycolysis/glycogenolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Lactate transport and metabolism in the human brain: implications for the astrocyte-neuron lactate shuttle hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

ALS, SOD and peroxynitrite

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20111943

21 January 2018

Identifiers

DOI

10.1042/BJ20111943

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22417747%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference